Xenetic Biosciences Inc. (XBIO)
NASDAQ · Healthcare
Xenetic Biosciences Inc. Price to FCF Ratio 2016–2026
Price to free cash flow (P/FCF) ratio for Xenetic Biosciences Inc. (XBIO): market cap divided by trailing twelve-month free cash flow. As of September 30, 2018 it is 2150.65.
From: 11/30/2012To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Xenetic Biosciences Inc. Price to FCF Ratio — FAQ
Xenetic Biosciences Inc. (XBIO) price to fcf ratio over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XBIO's price to fcf ratio history?
The chart and table above show Xenetic Biosciences Inc.'s price to fcf ratio by year and by quarter, including the growth rate.